R Verchovsky
Overview
Explore the profile of R Verchovsky including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
7
Citations
85
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Treves T, Verchovsky R, Klimovitzky S, Korczyn A
Int Psychogeriatr
. 2005 Jul;
17(2):265-73.
PMID: 16050435
Background: The risk of developing dementia by elderly patients with only subjective memory complaints (SMC) is unclear. Our objective was to assess the prognosis of such patients regarding subsequent development...
2.
Assaf Y, Gigi A, Ben-Bashat D, Mordohovitch M, Verchovsky R, Reider-Groswasser I, et al.
J Neurol Sci
. 2002 Nov;
203-204:235-9.
PMID: 12417390
High b value diffusion weighted magnetic resonance imaging (high-b DWI) was used to characterize white matter changes in the brain of patients with vascular dementia (VaD). Hyperintense white matter areas...
3.
Treves T, Verchovsky R, Klimovitsky S, Korczyn A
Alzheimer Dis Assoc Disord
. 2001 Feb;
14(4):209-11.
PMID: 11186598
Sample size calculations are important for planning drug trials and require anticipation of the proportion of potential patients finally recruited. Because most recent drug studies for dementia have similar requirements,...
4.
Elad P, Treves T, Drory M, Verchovsky R, Klimovitsky S, Yaron S, et al.
Int J Geriatr Psychiatry
. 2000 Apr;
15(4):325-30.
PMID: 10767732
Clinical trials for Alzheimer's disease take place in medical centers all over the world. Patients and caregivers have to decide whether or not to agree to participate in clinical trials....
5.
Apolipoprotein E4 in Parkinson disease and dementia: new data and meta-analysis of published studies
Inzelberg R, Chapman J, Treves T, Asherov A, Kipervasser S, Hilkewicz O, et al.
Alzheimer Dis Assoc Disord
. 1998 Apr;
12(1):45-8.
PMID: 9539410
The authors examined whether the epsilon4 allele might be associated with dementia in Parkinson disease (PD), given that the dementia of PD shares neuroanatomic and neurochemical features with Alzheimer disease...
6.
Fisher A, Heldman E, Gurwitz D, Haring R, Karton Y, Meshulam H, et al.
Ann N Y Acad Sci
. 1996 Jan;
777:189-96.
PMID: 8624083
The AF series compounds, AF102B and congeners of AF150(S), are functionally selective agonists for m1 muscarinic receptors (m1AChRs). This is shown in stable transfected CHO and PC12 cells (PC12M1) with...
7.
Treves T, Bornstein N, Chapman J, Klimovitzki S, Verchovsky R, Asherov A, et al.
Alzheimer Dis Assoc Disord
. 1996 Jan;
10(4):189-91.
PMID: 8939277
The apolipoprotein E (APOE) epsilon 4 allele has been consistently found to be frequent in patients with progressive degenerative dementia of the Alzheimer type (DAT). Vascular dementia (VD) may occur...